Swiss National Bank
PRAX icon

Swiss National Bank’s Praxis Precision Medicines PRAX Stock Holding History

Swiss National Bank’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Sell
46,100
-600
-1% -$190K 0.01% 805
2026
Q1 		$15M Buy
46,700
+6,200
+15% +$1.92M 0.01% 759
2025
Q4 		$11.9M Buy
40,500
+5,000
+14% +$931K 0.01% 872
2025
Q3 		$1.88M Buy
35,500
+4,700
+15% +$228K ﹤0.01% 1883
2025
Q2 		$1.3M Buy
30,800
+3,700
+14% +$141K ﹤0.01% 2019
2025
Q1 		$1.03M Buy
27,100
+1,000
+4% +$62.5K ﹤0.01% 2120
2024
Q4 		$2.01M Buy
26,100
+1,000
+4% +$72.4K ﹤0.01% 1850
2024
Q3 		$1.44M Sell
25,100
-6,900
-22% -$373K ﹤0.01% 2037
2024
Q2 		$1.32M Buy
+32,000
New +$1.51M ﹤0.01% 2030
2022
Q4 		– Sell
-5,720
Closed -$195K – 2713
2022
Q3 		$195K Hold
5,720
– – ﹤0.01% 2695
2022
Q2 		$210K Buy
5,720
+2,180
+62% +$233K ﹤0.01% 2730
2022
Q1 		$542K Buy
3,540
+260
+8% +$53.4K ﹤0.01% 2585
2021
Q4 		$969K Buy
3,280
+80
+3% +$23.5K ﹤0.01% 2491
2021
Q3 		$888K Hold
3,200
– – ﹤0.01% 2470
2021
Q2 		$877K Buy
+3,200
New +$1.15M ﹤0.01% 2526

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Swiss National Bank's PRAX Position: Q2 2026 in Review

Swiss National Bank reduced its Praxis Precision Medicines (PRAX) stake by 1.3% in Q2 2026, selling an estimated $190K and leaving 46,100 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #805.

Swiss National Bank first reported a position in PRAX in Q2 2021 and has held it in 15 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Swiss National Bank held 46,100 shares of Praxis Precision Medicines worth $15.4M as of Q2 2026.
  • Swiss National Bank sold 600 Praxis Precision Medicines shares in Q2 2026, an estimated $190K.
  • Praxis Precision Medicines made up 0.01% of Swiss National Bank's portfolio in Q2 2026, its #805 holding.
  • Swiss National Bank first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 15 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.